Search

Drawing on the author's experience in devising a localized version of The Vagina Monologues in Hong Kong, this paper critically appraises the 'global vaginahood' in the globalization of The Vagina Monologues and the V-Day movement that reproduces a core-periphery relationship in the transnational women's movement. As a theatrical performance and a worldwide movement, these productions are remarkable for the manner in which they raise awareness about women's sexuality and violence against women in different parts of the world. Critical questions, however, remain on the rhetoric of universalism and the ethnocentric methods of the global campaign, with US women's experiences and agenda defining those of women in other parts of the world. As a worldwide campaign, the V-Day movement reproduces a hierarchical model between the global North and South, with on emphasis on Western leadership rather than coalition between partners with different experiences, priorities, and strategies. The paper argues that feminists may develop more effective coalitions with local women by recognizing and identifying locally derived creative efforts to respond to issues that are pertinent to their lives. As such, the paper is a push for dialogues in the V-Day campaign and transnational women's movement in general. [ABSTRACT FROM AUTHOR]

The term 'obscenity' has no universal definition. It is often ill -defined, subjective and highly dependent on the culture of the communities in question and between communities. Nevertheless, the aim of the law on obscenity is to prevent publication and distribution of materials, which are potentially harmful to its readers, viewers and audience. The purpose of this paper is three fold. Firstly, it briefly considers the law on obscenity in the United Kingdom, and in the United States. Secondly, the paper discusses and evaluates the law relating to obscenity in Hong Kong in the light of the recent publication and distribution of materials which could be argued to fall within the realm of obscenity. Finally, it considers whether the law on obscenity would ever be able to fit into an "acceptable community standard". [ABSTRACT FROM AUTHOR]

The Shanghai-Hong Kong Stock Connect has been in operation for more than a year. It is predictable that with the implementation of this scheme, cross-border securities disputes between the Mainland and Hong Kong will be on the rise. In resolving these disputes, one of the most important problems is the determination of substantive law that should apply to them. This paper makes feasible proposals to harmonize the choice of law rules regarding cross-border securities disputes under the Shanghai-Hong Kong Stock Connect with due reference made to the approaches adopted by the Hague Convention on the Law Applicable to Certain Rights in Respect of Securities Held with an Intermediary and the Uniform Commercial Code of the US. [ABSTRACT FROM AUTHOR]

Please cite this paper as: Belshe et al. (2010). Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age. Influenza and Other Respiratory Viruses 4(3), 141–145. Background It has been suggested that live attenuated influenza vaccine (LAIV) may be less effective in older individuals because of prior wild-type influenza infections. LAIV is currently approved in the United States, South Korea and Hong Kong for individuals 2–49 years of age. Objective To examine data from previously published pediatric studies to determine the efficacy of LAIV in various age groups. Methods Four studies in which the subject age range exceeded 36 months were identified: one 2-year study comparing LAIV with placebo and three 1-year studies comparing LAIV with trivalent inactivated influenza vaccine (TIV). Efficacy against any strain regardless of antigenic similarity to vaccine was analyzed by age; age groups were based on the study design and sample size. A logistic regression model was used to assess whether age, as a continuous variable, was an effect modifier on LAIV efficacy. Results The efficacy of LAIV did not vary with age in children aged 15–84 months compared with placebo or in children aged 6 months to 17 years compared with TIV. Conclusions The available data from prospective, randomized studies in children does not support the concept that prior repeated exposure to influenza, either through wild-type infection or vaccination with live, attenuated or inactivated vaccines, reduces the efficacy of LAIV compared with placebo or TIV. The decreased immunologic responses to LAIV reported in older individuals or those with pre-existing immunity do not appear to translate into reduced protection from influenza in children. [ABSTRACT FROM AUTHOR]